HSIEN-LI KAOMAO-SHIN LINWEN-CHAU WUWEN-YIH TSENGMAO-YUAN SUYA-FANG CHENMING-JANG CHIUWang, Shan-YingShan-YingWangWEI-SHIUNG YANGKAI-YUAN TZENYEN-WEN WUMING-FONG CHEN2021-06-012021-06-012015-0903639762https://scholars.lib.ntu.edu.tw/handle/123456789/564429Neurocognitive performance among patients with carotid artery stenosis or occlusion may deteriorate because of chronic cerebral hypoperfusion. Carotid artery stenting (CAS) has been reported to improve cerebral perfusion and neurocognitive function. The purpose of the study was to evaluate cerebral metabolism using F-fluorodeoxyglucose (FDG) positron emission tomography (PET) after CAS.enCarotid artery stenting | Cerebral metabolism | Neurocognition | Perfusion | Positron emission tomographyCarotid artery stenting; Cerebral metabolism; Neurocognition; Perfusion; Positron emission tomography[SDGs]SDG3fluorodeoxyglucose f 18; glucose; fluorodeoxyglucose f 18; glucose; radiopharmaceutical agent; adult; aged; Alzheimer Disease Assessment Scale; Article; brain blood volume; brain ischemia; brain mapping; brain metabolism; brain perfusion; brain region; carotid artery obstruction; carotid artery stent; carotid artery stenting; clinical article; cognition; computed tomographic angiography; computed tomography scanner; disease severity; female; glucose metabolism; human; male; Mini Mental State Examination; nuclear magnetic resonance imaging; nuclear magnetic resonance scanner; PET-CT scanner; positron emission tomography; recanalization; self expandable metallic stent; treatment failure; brain cortex; Carotid Stenosis; metabolism; middle aged; positron emission tomography; scintiscanning; stent; Aged; Carotid Stenosis; Cerebral Cortex; Cognition; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stentsjournal article10.1097/RLU.0000000000000880261641742-s2.0-84939543868https://scholars.lib.ntu.edu.tw/handle/123456789/553487